Our brightest reporter gene assay for quantitation of firefly luciferase in mammalian cells, britelite™ Plus offers very high sensitivity, is designed for continuous process systems and higher density microplates.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Reporter Gene |
Assay Points | 100 |
Our brightest reporter gene assay for quantitation of firefly luciferase in mammalian cells, britelite™ Plus offers very high sensitivity, is designed for continuous process systems and higher density microplates.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Britelite™ plus is a homogeneous, ultra-high sensitivity luciferase reporter gene assay system quantitation of
firefly luciferase expression in mammalian cells. britelite reporter assay was designed to provide maximum signal
intensity assays requiring utmost sensitivity, and is suitable use in a 96-, 384-, or 1536-well microplate format.
With a signal half-life of 30 minutes, our britelite reporter gene assay is ideal for:
britelite plus benefits:
As with all members of Revvity's Lites suite of luciferase detection reagents, britelite plus offers superior
performance in an easy-to-use format, providing following benefits:
Application |
Reporter Gene
|
---|---|
Assay Points |
100
|
Automation Compatible |
Yes
|
Brand |
britelite plus
|
Cellular or Signaling Pathway |
DNA Transcription
Signal Transduction
|
Cellular Process |
DNA Transcription
Signal Transduction
|
Detection Modality |
Luminescence
|
Format |
Microplates
|
One Unit Contains |
10.0 mL
|
Signal Halflife |
0.5 hours
|
Shipping Conditions |
Shipped Ambient
|
Unit Size |
100 (96-well) / 400 (384-well)
|
Are you looking for resources, click on the resource type to explore further.
Chimeric antigen receptor (CAR) T-cell therapy has transformed the field of immuno-oncology providing a novel approach to treating...
We are here to answer your questions.